Turning scientific vision into successful biotech ventures takes more than great ideas—it demands resilience, timing, and knowing how to tell your story. Ever wondered how hard it really is to build a breakthrough life science company outside the established biotech epicenters?

This episode features an inspiring conversation with Dr. Lalo Flores, a serial biotech founder whose journey from Chile to Philadelphia’s startup scene reveals the critical lessons behind starting, funding, and scaling innovative therapeutics companies.

Key highlights include:

• The challenges and advantages of launching biotech companies away from the Bay Area and Boston
• How relationships, timing, and storytelling impact startup fundraising
• The evolution from academic scientist to biotech entrepreneur
• Strategies for overcoming capital droughts and shifting investor sentiment
• Real-world advice on capital efficiency, investor trends, and what's changing in the world of AI and biotech

Whether you’re contemplating your first startup, raising your Series A, or wondering how the industry weathered boom-and-bust cycles, Dr. Flores’s candid reflections bring hard-earned wisdom and optimism for the future of biotech innovation.

Timestamped Overview

[00:00] Introduction and guest background

[01:20] Early life, academic path, and first exposure to biotech

[04:49] Lessons from Big Pharma and moving to Pennsylvania

[08:53] Staying in Philadelphia: talent, family, and startup challenges

[10:19] Fundraising for Novira Therapeutics and early struggles

[14:11] Building technology and creating new IP

[17:12] Surviving near-death company moments and angel investing

[19:07] The process and timing of selling a biotech company

[20:15] Founding Century Therapeutics: the cell therapy revolution

[23:45] The biotech bubble and going public in 2021

[25:46] Reflections on IPOs, private vs public funding

[27:00] Market saturation and the pitfalls of biotech fads

[29:43] Building Flax Therapeutics and today’s fundraising climate

[32:23] Investor risk aversion and strategies for capital efficiency

[34:28] Comparing fundraising eras: then vs now

[37:45] Achieving key drug development milestones

[40:24] Going public again: decision points and syndicates

[41:29] Audience Q&A: Family offices, Series A timing, and what’s next

[47:26] Top three priorities after a successful raise

[50:33] AI’s impact on biotech startups and future opportunities

[56:32] Closing remarks and episode wrap-up

What if your child left their life-saving EpiPen at home on prom night—and it inspired a whole new medical device?

In this eye-opening episode, Dr. Edwin Pribitkin reveals the true story behind his invention: an auto-injector that attaches directly to your smartphone, born from a father’s panic and a daughter’s stubbornness.

Dive into the highs and lows of medical innovation as Dr. Edwin Pribitkin and Eric Hacherl explore what it really takes to bring a healthcare device from a sketch on the back of a napkin to the hands of millions—including lessons in failure, the complexities of building the right team, and why even world-class doctors have to learn new business skills.

Plus, get an insider look at Jefferson Health’s new venture arm and its mission of transforming ideas into impact for the Philadelphia life sciences community.

Episode Overview

[00:00] Introduction and background of Dr. Edwin Pribitkin[07:33] Dr. Edwin Pribitkin's unconventional journey into medicine[12:19] The origin story: how a prom night argument led to a life-saving invention[17:52] Moving from idea to patented product[18:21] Challenges of FDA approval and market validation[22:17] Proving the need: market research and user behavior[25:03] From prototype to startup: finding the right team[34:27] Projected timeline for commercialization[36:00] Evolving the device into a platform for other emergency medications[40:04] Jefferson’s venture and innovation strategy[44:27] The importance of team-building in healthcare entrepreneurship[49:37] Episode wrap-up and closing remarks

What if the most powerful lesson you’ll hear this week comes from a six-year-old’s first election loss?

In this episode of the Life Science Affinity Club podcast, legendary Philadelphia entrepreneur Brian Tierney reveals how a childhood lesson about voting for himself shaped his decades-long journey at the intersection of politics, business, and media. From his roots in Upper Darby to leading the Philadelphia Inquirer through tumultuous times, Brian Tierney shares how optimism, adaptability, and heartfelt connections fuel innovation.

He dives deep into building diverse teams, navigating tough decisions, and the art of storytelling—crucial for both scientists and entrepreneurs. You’ll also hear insider anecdotes about forging transformative relationships, from union leaders to Bono and Oprah, showing just how Philadelphia’s spirit can transcend doubt and drive impact on a global stage.

Episode Overview:

00:00 Welcome & introduction to the Life Science Affinity Club podcast

00:12 Brian Tierney's background, early influences, and lessons from family

01:51 Lessons in politics, voting for yourself, and youthful optimism

05:52 Insights from working in D.C. and the power of storytelling

08:28 Reagan, Tip O’Neill, and finding common ground

13:00 Taking risks with the Philadelphia Inquirer and building diverse teams

15:12 Navigating union relationships, leadership challenges, and business transformation

19:11 Buying the Inquirer and adapting to the digital age

23:10 Advice for life sciences entrepreneurs on branding and making tough decisions

28:11 Personal stories about hiring, risk, and the “what if we win?” mindset

31:22 Creating Philadelphia’s voice & standing out on the global stage

34:34 The impact of optimism—examples from tourism campaigns and overcoming skepticism

43:35 Audience Q&A: Diversifying news sources and embracing new experiences

48:30 Closing remarks & summary, Brian’s role as the “voice of Philadelphia”

49:11 Show wrap-up, sponsors, and subscription reminder

What if a simple change in a baby’s diet could prevent peanut allergies for life?

On this episode of the Life Science Affinity Club podcast, we reveal groundbreaking research that’s helping childhood food allergies decline—right in Philadelphia.

Host Robert Christmas sits down with Dr. David Hill, a pediatric allergist at Children’s Hospital of Philadelphia, to discuss what’s fueling the drop in peanut allergies, how science is turning lab discoveries into real-world diagnostics, and why having CHOP in Philadelphia puts this city on the global map for pediatric research.

From early life environmental factors and the origins of allergy, to the critical impact of philanthropy and how AI is accelerating breakthroughs, this episode is packed with insights for anyone passionate about the future of medicine, kids’ health, and innovation.

This episode was Sponsored this month by BioLaunch 360.  Visit www.biolaunch360.com for more information.

Key Highlights:

• The story behind declining peanut allergy rates and the LEAP trial’s impact
• How a Philadelphia mom’s question led to genome research on twins with contrasting allergies
• The surprising connection between environment, microbiome, and adult-onset allergies
• The privilege and pressures of running a pediatric research lab—and how philanthropy enables rapid action
• The exciting potential of AI tools in allergy research

Timestamped Overview:

• 00:00: Introduction and Dr. David Hill’s background
• 05:20: Bridging patient care and lab discoveries
• 08:22: Developing diagnostics from research
• 15:11: Peanut allergy research, LEAP trial, and early allergen introduction
• 19:45: CHOP’s impact and research passion
• 22:12: The role of philanthropy and grant dynamics
• 26:24: Science, skepticism, and policy
• 29:48: AI in medical research and CHOP’s support systems
• 33:51: Environmental influences on allergies—including antibiotics, birth methods, and processed foods
• 35:05: Genome research on twins and diagnostic test applications
• 38:25: Adult onset allergy origins and the microbiome
• 40:03: Closing remarks and CHOP’s role in pediatric innovation

Subscribe and tune in for an optimistic look at how science is delivering answers—and hope—to families everywhere.